Andrés Celestino
García Montero
Profesor Asociado
Publicaciones (108) Publicaciones de Andrés Celestino García Montero
2024
-
Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 711-723
-
T-cell immune profile in blood of systemic mastocytosis: Association with disease features
Allergy: European Journal of Allergy and Clinical Immunology
2023
-
Bone and Cytokine Markers Associated With Bone Disease in Systemic Mastocytosis
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 5, pp. 1536-1547
-
KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1347-1359
-
Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality
The journal of allergy and clinical immunology. In practice, Vol. 11, Núm. 3, pp. 908-919
2022
-
Altered innate immune profile in blood of systemic mastocytosis patients
Clinical and Translational Allergy, Vol. 12, Núm. 6
-
Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis
Cancers, Vol. 14, Núm. 10
-
Frequency and prognostic impact of blood-circulating tumor mast cells in mastocytosis
Blood, Vol. 139, Núm. 4, pp. 572-583
2021
-
Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosis
American Journal of Human Genetics, Vol. 108, Núm. 2, pp. 284-294
-
Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders
Annals of Allergy, Asthma and Immunology, Vol. 127, Núm. 4, pp. 427-434
-
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
The Lancet Haematology, Vol. 8, Núm. 3, pp. e194-e204
-
The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct Outcome
Frontiers in Oncology, Vol. 11
-
Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas
Frontiers in Oncology, Vol. 11
2019
-
Bone marrow mast cell antibody-targetable cell surface protein expression profiles in systemic mastocytosis
International Journal of Molecular Sciences, Vol. 20, Núm. 3
-
Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis
Blood, Vol. 134, Núm. 5, pp. 456-468
-
Frequency of clonal mast cell diseases among patients presenting with anaphylaxis: A prospective study in 178 patients from 5 tertiary centers in Spain
Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 8, pp. 2924-2926.e1
-
Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s disease
Pharmacogenomics Journal, Vol. 19, Núm. 6, pp. 547-555
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
-
Mars: Mutation-adjusted risk score for advanced systemic mastocytosis
Journal of Clinical Oncology, Vol. 37, Núm. 31, pp. 2846-2856
-
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases
Hematological Oncology, Vol. 37, Núm. 5, pp. 628-633